The Asia Pacific Biosurfactants Market was valued at $42.18 Million in 2025 and projected to reach to $64.01 Million by 2030, representing a compound annual growth rate of 8.7%. The Asia Pacific biosurfactants market is poised for steady expansion driven by increasing regulatory pressure for sustainable chemicals and growing consumer preference for eco-friendly products.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific biosurfactants market valued at $42.18 million in 2025, expanding at 8.7% CAGR to reach $64.01 million by 2030, demonstrating robust regional demand for sustainable surfactant solutions.
Rising consumer awareness across Asia Pacific drives adoption of eco-friendly biosurfactants in personal care and household detergents, reflecting regional shift toward sustainable product preferences.
Asia Pacific's expanding manufacturing base and industrial infrastructure create significant opportunities for biosurfactant production and application across multiple end-use sectors.
Growing utilization of biosurfactants in personal care, detergents, industrial cleaning, and agricultural applications positions Asia Pacific as a key growth market for sustainable chemical solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | –RHAMNOLIPIDS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 11.79% from 2025 to 2030 |
| Largest Segment | GLYCOLIPIDS (Type) |
| Market Size Base Year (Billions) | ~USD 1.66 (2025) |
| Revenue Forecast (Billions) | ~USD 2.89 (2030) |
| Segments Covered | Type, Application |
2 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| INGEVITY CORPORATION | United States | Public Company | Glycolipids – Sophorolipids,Glycolipids – Rhamnolipids,Lipopeptides, |
| UNILEVER PLC | United Kingdom | ||
| ADEKA CORPORATION | Japan | Public Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
| KAO CORPORATION | Japan | Public Company | Glycolipids – Sophorolipids,Glycolipids – Rhamnolipids,Lipopeptides, |
| OXITENO | Brazil | Private Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
| AZELIS HOLDINGS SA | Belgium | Private Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
| EVONIK INDUSTRIES AG | Germany | Public Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
| STEPAN COMPANY | United States | Public Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
| SOLVAY SA | Belgium | Public Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
| DOW INC. | United States | Public Company | Glycolipids – Sophorolipids,Glycolipids – Rhamnolipids,Lipopeptides, |
| KANEKA CORPORATION | Japan | Public Company | Glycolipids - Sophorolipids,Glycolipids - Rhamnolipids,Lipopeptides, |
Ingevity Corporation is a United States-based public company founded in 1964 with approximately 1,500 employees. The company operates as a specialty chemicals manufacturer serving various industrial sectors.
Insufficient data provided for business description.
Adeka Corporation is a Japanese public company founded in 1917 with 5,434 employees. The company operates in the specialty chemicals and additives sector.
Kao Corporation is a Japanese public company founded in 1887 with 31,514 employees. The company is a major manufacturer of consumer and specialty chemicals products.
Oxiteno is a Brazilian private company founded in 1971 with 1,829 employees. The company manufactures specialty chemicals and surfactants for industrial applications.
Azelis Holdings SA is a Belgian private company founded in 2001 with 1,325 employees. The company operates as a specialty chemicals distributor and manufacturer.
Evonik Industries AG is a German public company founded in 1847 with 30,643 employees. The company is a major global manufacturer of specialty chemicals and advanced materials.
Stepan Company is a United States-based public company founded in 1932 with 2,328 employees. The company manufactures specialty chemicals including surfactants and polymers.
Solvay SA is a Belgian public company founded in 1863 with 8,400 employees. The company is a global manufacturer of specialty chemicals and advanced materials.
Dow Inc. is a United States-based public company founded in 1897 with 32,800 employees. The company is a major global manufacturer of chemicals, plastics, and agricultural products.
Kaneka Corporation is a Japanese public company founded in 1949 with 11,762 employees. The company manufactures specialty chemicals, plastics, and advanced materials.
| Country | 2025 size (native) |
|---|---|
| China | USD 30.91 Million |
| Japan | USD 15.2 Million |
| South Korea | USD 4.62 Million |
| Rest Of Asia Pacific | USD 13.29 Million |
The Asia Pacific biosurfactants market was valued at $42.18 million in 2025 and is projected to reach $64.01 million by 2030.
Asia Pacific's biosurfactants market is expected to grow at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2030.
China, India, and Southeast Asian nations are among the leading markets in Asia Pacific, driven by manufacturing capacity, biotechnology investment, and regulatory support for sustainable chemicals.
Key drivers in Asia Pacific include rising consumer demand for eco-friendly products, government green chemistry initiatives, expanding industrial applications, and cost-competitive fermentation production capabilities.
Asia Pacific's 8.7% CAGR reflects strong regional momentum, with the region positioned as a critical hub for biosurfactant production and innovation, supported by favorable manufacturing economics and renewable feedstock availability.
The study involved four major activities in estimating the market size for the biosurfactants market. Exhaustive secondary research was conducted to gather information on the market, its peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, market breakdown and data triangulation procedures were employed to determine the market size of the segments and subsegments.
Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research, which involved conducting extensive interviews with key officials, including CEOs, VPs, directors, and other executives.
The biosurfactants market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized by key opinion leaders in various applications for the biosurfactants market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2023/2024, available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
|
COMPANY NAME |
DESIGNATION |
|
Evonik Industries AG |
Senior Manager |
|
Shaanxi Deguan Biotechnology Co., Ltd |
Innovation Manager |
|
Biotensidon GmbH |
Vice-President |
|
Saraya Co., Ltd. |
Production Supervisor |
|
Allied Carbon Solutions Co., Ltd. |
Sales Manager |
Both top-down and bottom-up approaches were used to estimate and validate the total size of the biosurfactants market. These methods were also used extensively to estimate the size of various market segments and subsegments. The research methodology used to estimate the market size included the following:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the biosurfactants industry.
According to ScienceAlert, “Biosurfactants can be defined as the surface-active biomolecules produced by microorganisms with a wide range of applications.” Biosurfactants are surface-active compounds produced by the biologically available raw materials through microbial fermentation. They are 100% biodegradable and exhibit superior foaming, wetting, emulsifying, and dispersing properties. Biosurfactants act as secondary metabolites that accumulate at the air-water or oil-water interfaces, forming micellar aggregates by reducing surface tension.
Key Stakeholders
Report Objectives
Along with the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional Analysis
Further breakdown of a region with respect to a particular country or additional application
Company Information
Detailed analysis and profiles of additional market players (up to five)
Full forecast, segment splits, and company analysis for all Biosurfactants Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report